The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DGM1 may serve as a novel genetic biomarker of response to enzastaurin in glioblastoma.
 
Nicholas A. Butowski
Honoraria - Vascular Biogenics; Vascular Biogenics
Consulting or Advisory Role - Abbvie; Genentech/Roche; Medicenna; Omniox
Speakers' Bureau - Genentech/Roche
Research Funding - Abbvie; Bristol-Myers Squibb; Five Prime Therapeutics; Lilly; Medicenna; Merck; Merrimack; Tocagen
 
Ronald L. Shazer
Employment - Denovo Biopharma; Inspyr Therapeutics
Leadership - Denovo Biopharma; Inspyr Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb; Pfizer
 
Hong Sun
Employment - Denovo Biopharma
Stock and Other Ownership Interests - Pfizer
 
Isabel Han
Employment - Denovo Biopharma
Travel, Accommodations, Expenses - Denovo Biopharma
 
Manoj A. Jivani
Employment - Denovo Biopharma; TRACON Pharma
Stock and Other Ownership Interests - TRACON Pharma
 
Wen Luo
Employment - Denovo Biopharma
Leadership - Denovo Biopharma
Stock and Other Ownership Interests - Denovo Biopharma
Research Funding - Denovo Biopharma
Patents, Royalties, Other Intellectual Property - Inventor of several Denovo Biopharma's patents; Inventor of several Denovo Biopharma's patents
Travel, Accommodations, Expenses - Denovo Biopharma